Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin
Open Access
- 13 November 1995
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 375 (1-2), 103-107
- https://doi.org/10.1016/0014-5793(95)01190-p
Abstract
Crystal structures of DX9065a and a related bisamidino‐aryl inhibitor specific for the blood‐clotting factor Xa have been solved in complex with bovine β‐trypsin to a resolution of 1.9 Å. Each inhibitor exhibits an extended conformation along the active site, in contrast to the compact folded structures observed for thrombin specific inhibitors. Few direct contacts (predominantly in the S1 pocket) are made between trypsin and the inhibitors. Transfer of the inhibitors to the active site of factor Xa suggests a three‐site interaction: salt bridge formation at the base of the primary specificity pocket, extensive hydrophobic surface burial and a weak electrostatic interaction between the distal basic component of the inhibitor and an electronegative cavity of factor Xa formed by three backbone carbonyl oxygens. Additivity of these three interactions is the basis for the observed strong inhibition of factor Xa and provides a framework for the design of novel factor Xa inhibitors. A propionic acid group of the inhibitor would clash with the thrombin specific ‘60‐insertion loop’, thus conferring selectivity against thrombin.Keywords
This publication has 29 references indexed in Scilit:
- Molecular model of an interaction between factor Xa and DX-9065a, a novel factor Xa inhibitor: Contribution of the acetimidoylpyrrolidine moiety of the inhibitor to potency and selectivity for serine proteasesEuropean Journal of Medicinal Chemistry, 1995
- Proposed cation‐π mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognitionFEBS Letters, 1995
- The clot thickens: clues provided by thrombin structureTrends in Biochemical Sciences, 1995
- A Novel Factor Xa Inhibitor: Structure-Activity Relationships and Selectivity between Factor Xa and ThrombinBiochemical and Biophysical Research Communications, 1993
- Structure of Human Des(1-45) Factor Xa at 2·2 Å ResolutionJournal of Molecular Biology, 1993
- Refined 2·3ÅX-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA: A starting point for improving antithromboticsJournal of Molecular Biology, 1992
- Geometry of binding of the Nα‐tosylated piperidides of m‐amidino‐, p‐amidino‐ and p‐guanidino phenylalanine to thrombin and trypsinFEBS Letters, 1991
- Geometry of binding of the benzamidine‐ and arginine‐based inhibitors Nα‐(2‐naphthyl‐sulphonyl‐glycyl)‐dl‐p‐amidinophenylalanyl‐piperidine (NAPAP) and (2R,4R)‐4‐methyl‐1‐[Nα‐(3‐methyl‐1,2,3,4‐tetrahydro‐8‐quinolinesulphonyl)‐l‐arginyl]‐2‐piperidine carboxylic acid (MQPA) to human α‐thrombinEuropean Journal of Biochemistry, 1990
- On the disordered activation domain in trypsinogen: chemical labelling and low-temperature crystallographyActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1982
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977